• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱法测定螺内酯及其代谢产物的血清浓度。

Determination of the serum concentration of spironolactone and its metabolites by high-performance liquid chromatography.

作者信息

Overdiek J W, Hermens W A, Merkus F W

出版信息

J Chromatogr. 1985 Jun 14;341(2):279-85. doi: 10.1016/s0378-4347(00)84041-4.

DOI:10.1016/s0378-4347(00)84041-4
PMID:4030980
Abstract

A simple and rapid high-performance liquid chromatographic assay is described for the simultaneous determination in serum of the aldosterone antagonist spironolactone and its metabolites 7 alpha-thiomethylspirolactone, 6 beta-hydroxy-7 alpha-thiomethylspirolactone and canrenone. Ultraviolet absorption at 240 nm was used to detect the different compounds after elution on a normal-phase column. Endogenous serum substances did not interfere with the assay. This method provides a convenient tool in pharmacokinetic studies of spironolactone, in contrast to previously reported aspecific fluorimetric assays or time-consuming thin-layer chromatographic analyses of radioactive biological material.

摘要

本文描述了一种简单快速的高效液相色谱法,用于同时测定血清中醛固酮拮抗剂螺内酯及其代谢物7α-硫甲基螺内酯、6β-羟基-7α-硫甲基螺内酯和坎利酮。在正相柱上洗脱后,利用240nm处的紫外吸收检测不同化合物。内源性血清物质不干扰该测定。与先前报道的非特异性荧光测定法或对放射性生物材料进行耗时的薄层色谱分析相比,该方法为螺内酯的药代动力学研究提供了一种便捷工具。

相似文献

1
Determination of the serum concentration of spironolactone and its metabolites by high-performance liquid chromatography.采用高效液相色谱法测定螺内酯及其代谢产物的血清浓度。
J Chromatogr. 1985 Jun 14;341(2):279-85. doi: 10.1016/s0378-4347(00)84041-4.
2
Simultaneous determination of spironolactone and its metabolites in human plasma.同时测定人血浆中螺内酯及其代谢物。
J Pharm Biomed Anal. 1996 Jun;14(8-10):1359-65. doi: 10.1016/s0731-7085(96)01767-0.
3
Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples.一种用于测定儿科血浆样本中螺内酯及其代谢物的高效液相色谱法的开发与验证
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jul 24;839(1-2):36-44. doi: 10.1016/j.jchromb.2006.02.017. Epub 2006 Feb 28.
4
New insights into the pharmacokinetics of spironolactone.螺内酯药代动力学的新见解。
Clin Pharmacol Ther. 1985 Oct;38(4):469-74. doi: 10.1038/clpt.1985.206.
5
High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum.用于分离和定量测定水性制剂中螺内酯及其降解产物以及大鼠血清中其代谢物的高效液相色谱法。
J Chromatogr A. 1998 Feb 27;797(1-2):271-81. doi: 10.1016/s0021-9673(97)01167-9.
6
High-performance liquid chromatographic determination of spironolactone and its major metabolite canrenone in urine using ultraviolet detection and column-switching.采用紫外检测和柱切换的高效液相色谱法测定尿液中的螺内酯及其主要代谢物坎利酮。
J Chromatogr B Biomed Appl. 1994 Aug 19;658(2):303-10. doi: 10.1016/0378-4347(94)00241-x.
7
Determination of canrenone, the major metabolite of spironolactone, in plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定血浆和尿液中螺内酯的主要代谢物坎利酮。
J Chromatogr. 1983 Oct 14;277:191-9. doi: 10.1016/s0378-4347(00)84836-7.
8
Analysis of metabolites--a new approach to bioequivalence studies of spironolactone formulations.代谢物分析——螺内酯制剂生物等效性研究的新方法。
Int J Clin Pharmacol Ther. 1997 Aug;35(8):334-40.
9
Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays.螺内酯代谢物与四种地高辛免疫测定法交叉反应性的重新评估。
Ther Drug Monit. 1989;11(2):200-4. doi: 10.1097/00007691-198903000-00013.
10
Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites.螺内酯代谢:含硫代谢产物的稳态血清水平。
J Clin Pharmacol. 1989 Apr;29(4):342-7. doi: 10.1002/j.1552-4604.1989.tb03339.x.

引用本文的文献

1
Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone.Pannexin 1 通道作为抗高血压药物螺内酯的一个意外新靶点。
Circ Res. 2018 Feb 16;122(4):606-615. doi: 10.1161/CIRCRESAHA.117.312380. Epub 2017 Dec 13.
2
Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.螺内酯对先天性肾上腺皮质增生症新生儿筛查的影响。
Arch Dis Child Fetal Neonatal Ed. 1999 Nov;81(3):F179-83. doi: 10.1136/fn.81.3.f179.
3
Improved bioavailability from a spironolactone beta-cyclodextrin complex.
螺内酯β-环糊精复合物提高了生物利用度。
Eur J Clin Pharmacol. 1991;40(5):507-11. doi: 10.1007/BF00315231.
4
Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.地高辛在人体中的相互作用:螺内酯降低地高辛的肾脏清除率,但不降低其胆汁清除率。
Eur J Clin Pharmacol. 1992;42(5):481-5. doi: 10.1007/BF00314854.